Allergan reports 3Q loss

Markets Associated Press

Allergan PLC (AGN) on Wednesday reported a third-quarter loss of $4.03 billion, after reporting a profit in the same period a year earlier.

Continue Reading Below

On a per-share basis, the Dublin-based company said it had a loss of $12.07. Earnings, adjusted for one-time gains and costs, came to $4.15 per share.

The results topped Wall Street expectations. The average estimate of 19 analysts surveyed by Zacks Investment Research was for earnings of $4.06 per share.

The Botox maker posted revenue of $4.03 billion in the period, which matched Street forecasts.

Allergan expects full-year earnings in the range of $16.15 to $16.45 per share, with revenue in the range of $15.88 billion to $16.02 billion.

Allergan shares have dropped 16 percent since the beginning of the year, while the Standard & Poor's 500 index has risen 15 percent. The stock has fallen 15 percent in the last 12 months.

Continue Reading Below

_____

This story was generated by Automated Insights using data from Zacks Investment Research. Access a Zacks stock report on AGN at https://www.zacks.com/ap/AGN